';
Mental Health

Maternal Mental Health and Substance Use Disorder Discussion

Friday, February 19, 2021 from 11:00 am – 1:00 pm

The Pennsylvania Commission for Women is hosting this event to bring awareness to maternal mental health and the stigma associated with substance use disorders. The panelists will discuss Opioid Use Disorder, Fetal Alcohol Spectrum Disorders (FASDs), and the Healthy Families America Safe Start program. There will also be a brief question and answers (Q&A) session at the end of the presentation. This event will be recorded and made available on the commission website.

Panelists:

  • Melissa Patti, MSW, LCSW – Director of Program Initiatives at the Maternity Care Coalition
  • Gary Stoner, MD – Director, Women’s Health Opioid Use Disorder (OUD) Program at Geisinger Medical Center
  • Robin VanEerden, MS, LPC, NADD-CC – Clinical Director of Intellectual Disabilities Division at Merakey

For more information on this event, see this flyer.

The Office of Mental Health and Substance Abuse Services (OMHSAS) has released guidance information confirming that OMHSAS programs are indeed in Phase 1A of Pennsylvania’s Interim Vaccination Plan for providers who are seeking to obtain vaccinations for their programs. While this particular response focuses on the Federal Pharmacy Partnership Program as a pathway to vaccinations, we are recommending that providers seek all available options that include federally-qualified health centers (FQHC’s), hospital and regional health systems, and county boards of health.

The Pennsylvania Department of Health (DOH) has made available a map of vaccine providers to assist your efforts. Please contact your RCPA policy director for any assistance you may need in your efforts. RCPA will continue to update its members on any changes in the plan.

OMHSAS Guidance

In order to facilitate vaccine distribution across Pennsylvania, Secretary of Health Dr. Rachel Levine signed an order on December 30, 2020 directing that at least ten percent of each vaccine shipment to hospitals, health systems, federally-qualified health centers, and pharmacies (collectively called “vaccine providers”) be designated for non-hospital affiliated health-care personnel who would otherwise be included in Phase 1A of Pennsylvania’s Interim Vaccination Plan, which was updated on Friday, January 8, 2021.

Health-care personnel as defined in Phase 1A include:

  • Physicians, nurses, nursing assistants, technicians, therapists, phlebotomists, emergency medical service personnel, direct support professionals (in-home and community-based services and adult day facilities), staff of long-term care facilities that have residents prioritized in 1A, staff in residential care providers serving children, pharmacists, clinical personnel in school settings or correctional facilities, and contractual staff working in but not employed by the health-care facility. People who are not involved in patient care but who could be exposed to COVID-19 through careers in dietary services, environmental services, laundry services, security, maintenance, facilities management, and other administrative services as defined in the Interim Vaccination Plan are also included.

Long-term care facility staff are considered health-care personnel above, and long-term care facility residents are also in Phase 1A. Long-term care facilities as defined in Phase 1A include:

  • Skilled nursing facilities, personal care homes, assisted living facilities, private intermediate care facilities for individuals with developmental disabilities, community group homes, residential treatment facilities for adults, long-term structured residences, state veterans homes, state centers, private psychiatric hospitals, and state hospitals.

The Department of Health recently released a map of vaccine providers who can administer a COVID-19 vaccine to anyone covered by Phase 1A. Anyone covered under Phase 1A who has not yet received a COVID-19 vaccine can contact any of these providers to check availability and schedule their vaccination, but we encourage providers to contact sites and coordinate for their employees who are eligible. Employees should be prepared to show proof of employment. This map is being updated regularly, so please keep checking for new locations with vaccine supply and available appointments.

Long-term care facility staff and residents may be eligible for the Federal Pharmacy Partnership Program for long-term care facilities. The Federal Pharmacy Partnership Program is currently prioritizing skilled nursing facilities at this time. If your facility is enrolled in the program, CVS and Walgreens may have already reached out to schedule a vaccination date with you. However, if your facility has not already scheduled a vaccination date with CVS or Walgreens, you are encouraged to contact your local vaccine provider. The Department of Human Services (DHS) and Department of Health are also working together on additional solutions to expedite vaccine distribution to DHS-licensed facilities. Please keep track of who in your facility has already received a vaccine.

As vaccine supply is limited, it may take some time to find a vaccination provider and appointment. Thank you for your patience through this process, and most importantly, thank you for being united in our collective fight against COVID-19.

MEDIA, PENNSYLVANIA — CareLink Community Support Services announced today that Gary Woomer has been appointed Interim CEO of the nonprofit agency. Mr. Woomer, an experienced leader and mental healthcare professional, succeeded Eileen M. Joseph and assumed responsibilities on December 10, 2020. Ms. Joseph retired from CareLink after leading the agency for nearly 40 years.

“Eileen Joseph had been a part of CareLink since 1981 and steered the agency through phenomenal growth,” said CareLink Board Chair Scot Stetka. “We appreciate her contributions and wish her well.”

Mr. Woomer joined CareLink as a Program Director in 1999, and has since served as a Regional Director, Vice President of Program Operations, and Chief Operating Officer. Prior to his tenure at CareLink, Mr. Woomer was employed at Prime Care, Inc. in West Chester, Pennsylvania.

“Gary Woomer has been with CareLink for more than 20 years,” Mr. Stetka said. “He stepped into his new role equipped with a wealth of industry experience, strong leadership skills, and a comprehensive understanding of the agency. We are confident that he can maintain the momentum necessary to keep CareLink moving forward as Interim CEO.”

Mr. Woomer received an Executive Leadership Certificate from the Nonprofit Executive Leadership Institute at Bryn Mawr College in 2019, a master’s degree in health services administration from the University of St. Francis in 1998, and a bachelor’s in psychology from Shippensburg University in 1989. He is currently a member of the Philadelphia Alliance of MH/MR/SA Agencies, the Rehabilitation and Community Providers Association, the Montgomery County Association for Excellence, and the Psychiatric Rehabilitation Association.

###

Since 1959, CareLink Community Support Services has been dedicated to providing people with mental illness and developmental disabilities with the caring support they need to live, work, and participate in the community with dignity and independence. Today, CareLink serves individuals in 33 community programs throughout Southeastern Pennsylvania and Southern New Jersey.

Media Contact: 

Kate Rosin
CareLink Community Support Services
krosin@carelinkservices.org
(610)-874-1119, ext. 613
www.carelinkservices.org

Photo by Markus Winkler on Unsplash

Yesterday, the Wolf Administration launched an interactive vaccine provider map. This map shows enrolled vaccine providers and indicates which providers have received vaccines to date. In addition to highlighting the status of vaccines available, this map also includes contact information to connect Phase 1A eligible individuals who are not affiliated with a hospital/health system with vaccines.

The map is also provided on the Department of Health’s (DOH’s) main COVID-19 vaccine page. DOH will continue to update this resource as information becomes available.

Photo by CDC on Unsplash

The Pennsylvania Department of Health (DOH) is supplying guidance on COVID-19 vaccination for providers. The information in 2021- PAHAN- 545- 01-06- ADV should be used to supplement other relevant guidance documents and guide the implementation of public health expectations for vaccine providers.

Key messages included in the guidance include:

  • There are two mRNA vaccines with 90 – 95 percent efficacy in preventing clinical COVID-19 currently available through an Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA) in the United States.
  • The only absolute contraindication to COVID-19 vaccination is a history of an immediate allergic reaction to either COVID-19 vaccine or any of their components.
  • Severe adverse reactions are uncommon, but vaccine providers should be prepared for this rare event.
  • Vaccine providers should report all adverse events following vaccination to the Vaccine Adverse Event Recording System (VAERS).
  • All COVID-19 mitigation measures should continue to be followed after vaccination.